Chen C, Dorado Garcia H, Scheer M, Henssen AG. Current and future treatment strategies for rhabdomyosarcoma. Front Oncol. 2019;9:1458.

Article  PubMed  PubMed Central  Google Scholar 

Paulino AC, Okcu MF. Rhabdomyosarcoma. Curr Probl Cancer. 2008;32:7–34.

Article  PubMed  Google Scholar 

Dobson CC, Langlois S, Grynspan D, Cowan KN, Holcik M. Engaging cell death pathways for the treatment of rhabdomyosarcoma. Crit Rev Oncog. 2016;21:221–39.

Article  PubMed  Google Scholar 

Malempati S, Hawkins DS. Rhabdomyosarcoma: review of the Children’s Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies. Pediatr Blood Cancer. 2012;59:5–10.

Article  PubMed  PubMed Central  Google Scholar 

Parham DM, Barr FG. Classification of rhabdomyosarcoma and its molecular basis. Adv Anat Pathol. 2013;20:387–97.

Article  PubMed  PubMed Central  Google Scholar 

Punyko JA, Mertens AC, Gurney JG, Yasui Y, Donaldson SS, Rodeberg DA, et al. Long-term medical effects of childhood and adolescent rhabdomyosarcoma: a report from the childhood cancer survivor study. Pediatr Blood Cancer. 2005;44:643–53.

Article  PubMed  Google Scholar 

Zarrabi A, Perrin D, Kavoosi M, Sommer M, Sezen S, Mehrbod P, et al. Rhabdomyosarcoma: current therapy, challenges, and future approaches to treatment strategies. Cancers. 2023;15:5269.

Article  PubMed  PubMed Central  Google Scholar 

Chisholm JC, Marandet J, Rey A, Scopinaro M, de Toledo JS, Merks JHM, et al. Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy. J Clin Oncol. 2011;29:1319–25.

Article  PubMed  Google Scholar 

Dasgupta R, Fuchs J, Rodeberg D. Rhabdomyosarcoma. Semin Pediatr Surg. 2016;25:276–83.

Article  PubMed  Google Scholar 

Biressi S, Molinaro M, Cossu G. Cellular heterogeneity during vertebrate skeletal muscle development. Dev Biol. 2007;308:281–93.

Article  PubMed  Google Scholar 

Hettmer S, Li Z, Billin AN, Barr FG, Cornelison DDW, Ehrlich AR, et al. Rhabdomyosarcoma: current challenges and their implications for developing therapies. Cold Spring Harb Perspect Med. 2014;4:a025650.

Article  PubMed  PubMed Central  Google Scholar 

Nanni P, Nicoletti G, Palladini A, Astolfi A, Rinella P, Croci S, et al. Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4. Mol Cancer Ther. 2009;8:754–61.

Article  PubMed  Google Scholar 

Wu Y-L, Yang A-H, Chiu Y-H. Recent advances in the structure and activation mechanisms of metabolite-releasing Pannexin 1 channels. Biochem Soc Trans. 2023;51:1687–99.

Article  PubMed  Google Scholar 

Zoidl G, Petrasch-Parwez E, Ray A, Meier C, Bunse S, Habbes H-W, et al. Localization of the pannexin1 protein at postsynaptic sites in the cerebral cortex and hippocampus. Neuroscience. 2007;146:9–16.

Article  PubMed  Google Scholar 

Langlois S, Cowan KN. Regulation of skeletal muscle myoblast differentiation and proliferation by Pannexins. Adv Exp Med Biol. 2017;925:57–73.

Article  PubMed  Google Scholar 

Alhouayek M, Sorti R, Gilthorpe JD, Fowler CJ. Role of pannexin-1 in the cellular uptake, release and hydrolysis of anandamide by T84 colon cancer cells. Sci Rep. 2019;9:7622.

Article  PubMed  PubMed Central  Google Scholar 

Penuela S, Bhalla R, Gong X-Q, Cowan KN, Celetti SJ, Cowan BJ, et al. Pannexin 1 and pannexin 3 are glycoproteins that exhibit many distinct characteristics from the connexin family of gap junction proteins. J Cell Sci. 2007;120:3772–83.

Article  PubMed  Google Scholar 

Cowan KN, Langlois S, Penuela S, Cowan BJ, Laird DW. Pannexin1 and Pannexin3 exhibit distinct localization patterns in human skin appendages and are regulated during keratinocyte differentiation and carcinogenesis. Cell Commun Adhes. 2012;19:45–53.

Article  PubMed  Google Scholar 

Pelegrin P, Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J. 2006;25:5071–82.

Article  PubMed  PubMed Central  Google Scholar 

Bruzzone R, Hormuzdi SG, Barbe MT, Herb A, Monyer H. Pannexins, a family of gap junction proteins expressed in brain. Proc Natl Acad Sci USA. 2003;100:13644–9.

Article  PubMed  PubMed Central  Google Scholar 

Celetti SJ, Cowan KN, Penuela S, Shao Q, Churko J, Laird DW. Implications of pannexin 1 and pannexin 3 for keratinocyte differentiation. J Cell Sci. 2010;123:1363–72.

Article  PubMed  Google Scholar 

Langlois S, Xiang X, Young K, Cowan BJ, Penuela S, Cowan KN. Pannexin 1 and pannexin 3 channels regulate skeletal muscle myoblast proliferation and differentiation. J Biol Chem. 2014;289:30717–31.

Article  PubMed  PubMed Central  Google Scholar 

Pham TL, St-Pierre M-E, Ravel-Chapuis A, Parks TEC, Langlois S, Penuela S, et al. Expression of Pannexin 1 and Pannexin 3 during skeletal muscle development, regeneration, and Duchenne muscular dystrophy. J Cell Physiol. 2018;233:7057–70.

Article  PubMed  Google Scholar 

Suarez-Berumen K, Collins-Hooper H, Gromova A, Meech R, Sacco A, Dash PR, et al. Pannexin 1 regulates skeletal muscle regeneration by promoting bleb-based myoblast migration and fusion through a novel lipid based signaling mechanism. Front Cell Dev Biol. 2021;9:736813.

Article  PubMed  PubMed Central  Google Scholar 

Freeman E, Langlois S, Scott K, Ravel-Chapuis A, Jasmin BJ, Cowan KN. Sex-dependent role of Pannexin 1 in regulating skeletal muscle and satellite cell function. J Cell Physiol. 2022;237:3944–59.

Article  PubMed  Google Scholar 

Xiang X, Langlois S, St-Pierre M-E, Barré JF, Grynspan D, Purgina B, et al. Pannexin 1 inhibits rhabdomyosarcoma progression through a mechanism independent of its canonical channel function. Oncogenesis. 2018;7:89.

Article  PubMed  PubMed Central  Google Scholar 

Xiang X, Hoang H-D, Gilchrist VH, Langlois S, Alain T, Cowan KN. Quercetin induces pannexin 1 expression via an alternative transcript with a translationally active 5’ leader in rhabdomyosarcoma. Oncogenesis. 2022;11:9.

Article  PubMed  PubMed Central  Google Scholar 

Xiang X, Langlois S, St-Pierre M-E, Blinder A, Charron P, Graber TE, et al. Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAK. Oncogene. 2021;40:1868–83.

Article  PubMed  PubMed Central  Google Scholar 

Sato Y, Probst HC, Tatsumi R, Ikeuchi Y, Neuberger MS, Rada C. Deficiency in APOBEC2 leads to a shift in muscle fiber type, diminished body mass, and myopathy. J Biol Chem. 2010;285:7111–8.

Article  PubMed  Google Scholar 

Liao W, Hong SH, Chan BH, Rudolph FB, Clark SC, Chan L. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family. Biochem Biophys Res Commun. 1999;260:398–404.

Article  PubMed  Google Scholar 

Conticello SG. The AID/APOBEC family of nucleic acid mutators. Genome Biol. 2008;9:229.

Article  PubMed  PubMed Central  Google Scholar 

Ohtsubo H, Sato Y, Suzuki T, Mizunoya W, Nakamura M, Tatsumi R, et al. APOBEC2 negatively regulates myoblast differentiation in muscle regeneration. Int J Biochem Cell Biol. 2017;85:91–101.

Article  PubMed  Google Scholar 

Lorenzo JP, Molla L, Amro EM, Ibarra IL, Ruf S, Neber C, et al. APOBEC2 safeguards skeletal muscle cell fate through binding chromatin and regulating transcription of non-muscle genes during myoblast differentiation. Proc Natl Acad Sci USA. 2024;121:e2312330121.

Article  PubMed  PubMed Central